‘This is the largest drug price cut in U.S. history,’ Trump proclaimed, assuring citizens they’ll save significantly and stay healthier. The platform embodies his aggressive stance on ‘America First’ healthcare, confronting what he calls an unfair system where foreigners snag U.S. drugs cheaply while Americans foot the bill.

Under the Most Favored Nation model, the U.S. will pay no more than any other country’s price for the same drug. Trump explained: ‘We’re taking the lowest price anywhere in the world. That’s what you’ll pay.’ He lambasted decades of subsidization: ‘Americans have been paying more so others pay less—those days are over.’

Major pharma players are on board: 16 of 17 top global firms signed deals, committing even future drugs to global low-price standards. Trump tied this to his tariff leverage, noting warnings to nations that refusal would spike their own costs, forcing compliance.

CMS head Mehmet Oz highlighted real-world impact: ‘Check the site before buying—today’s discounts end the era where one-third of patients leave pharmacies empty-handed.’ Launching with 40+ drugs from key manufacturers like Pfizer and Novo Nordisk, the site offers seamless coupon access and plans expansions.

Backed by a 2025 executive order, industry letters, and recent pacts, this initiative culminates in Trump’s push for congressional approval of his comprehensive ‘Great Healthcare Plan.’ Critics of high drug costs will watch closely as TrumpRx.gov tests whether market pressure can truly democratize affordable medicine.

The spark ignited during the pandemic when Jain witnessed families crippled by exorbitant medical bills. Focusing on electrocardiograms (ECGs) and biomarker analysis, his team engineered a compact diagnostic kit that rivals imported machines but costs 80% less.

Startup India’s ecosystem played a pivotal role—from DPIIT recognition to access to angel investors. Within two years, the startup scaled production, employing 50 locals and exporting prototypes to Southeast Asia.

What sets this apart? The device’s machine-learning algorithms analyze data in real-time, flagging risks like arrhythmias or blockages with 95% precision. Users simply attach sensors to their chest, sync with an app, and get a report in minutes.

Health experts hail it as a game-changer. ‘This bridges the urban-rural divide in cardiac care,’ notes Dr. Meera Singh, a leading cardiologist. Adoption is surging: from Uttarakhand villages to Delhi slums, it’s becoming a household name.

Jain’s story is inspirational. ‘Innovation thrives when supported by policy,’ he reflects. With plans for nationwide expansion, his venture exemplifies how startups can tackle India’s biggest health challenges head-on.

Practicing in areas like Haidernagar, Ramna, and Nagar Untari for many years, Dr. Singh was a beacon of hope for countless patients. Unlike many in the medical profession, he never exploited patients, refraining from unnecessary tests or creating financial burdens. His clinic doors were always open, 24 hours a day, reflecting his unwavering commitment to accessible healthcare. Even when he moved to Daltonganj due to declining health and age, patients continued to seek his expertise. He initially agreed to a private hospital’s request to practice there, insisting on his ₹5 fee, but eventually conceded to ₹50 under pressure from the hospital administration, a testament to his flexibility in ensuring continued patient care.

Born in a modest family in Murma village, Dr. Singh deeply understood the struggles of the poor, having experienced a challenging educational journey himself. His simple lifestyle and profound respect for relationships, especially with his community, defined his character. He embodied the true spirit of a physician, earning him the title ‘God on Earth’ through his selfless service and dedication. His legacy serves as an inspiration, reminding us of the profound impact one individual can have through empathy and unwavering commitment to the well-being of others.